US COURT DISMISSES PATENT INFRINGEMENT SUIT AGAINST L’ORÉAL
THE WHAT? A District of Columbia federal court has thrown out a case bought by GlycoBioSciences charging L’Oréal with patent infringement, citing a lack of jurisdiction, according to a report published by Law Street Media.
THE DETAILS The Canadian cosmetics and pharmaceutical company claimed that L’Oréal SA infringed its US patents for a specific gel and polymer matrix.
THE WHY? The case was dismissed over a lack of jurisdiction with Judge Beryl Howell ruling that the French beauty giant does not have sufficient contacts within the US as it is distinct from its US subsidiary, which has its own licensing and distribution agreements. The court did not comment on whether the French beauty giant did or did not infringe the patents in question or not.
You May Interested In
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
L’Oréal Middle East Partners with BinSina Pharmacy to Promote Sustainable Beauty in the UAE
-
L’Oréal and Tru Diagnostic Collaborate on Epigenomic Research in Beauty and Personal Care
-
L’Oréal Opens New $160 Million R&D Center in New Jersey
-
L’Oréal and IBM Partner to Develop AI Models to Formulate More Sustainable Cosmetics
-
L’Oréal partners with Abolis Biotechnologies and Evonik to advance sustainable biobased beauty goals
-
H1 2024: L’Oréal stellar despite China blemishes
-
L’Oréal acquires 10% stake in Galderma
-
Galderma and L’Oréal enter into a scientific partnership
-
Debut and L’Oréal are developing more than 12 bioidentical, biobased alternatives to traditional cosmetic ingredients
Recommend Reading
-
BASF’s €8.7 Billion Zhanjiang Verbund Site Fully Operational
-
Procter & Gamble Exits Pakistan Amid Economic Pressures, Ending Three Decades of Operations
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Covestro Minority Shareholder Squeeze-Out Price Set at €59.46 per Share
-
Both Cost and Demand Weaken, PTA Prices Slightly Decline
-
Sulfuric Acid Reactions: With Sugar (Dehydration), Water, and Metals
-
Cost-side support weakens, polyester staple fiber prices slightly decline
-
What is Serine? (Amino Acid Function & Sources)
-
Significant Supply Increase, Acrylonitrile Market Weak and Fluctuating